专利检索 ap:("Medigen Vaccine Biologics Corporation" OR "Dynavax Technologies Corporation") AND inv:"Charles CHEN" 第 1 页

1.

发明申请
CORONAVIRUS VACCINES COMPRISING A TLR9 AGONIST 有权

公开(公告)号：US20230110516A1

公开(公告)日：2023-04-13

申请号：US17908222

申请日：2021-03-01

申请人： Dynavax Technologies Corporation , MEDIGEN VACCINE BIOLOGICS CORPORATION

发明人： John D. CAMPBELL , Robert S. JANSSEN , David NOVACK , Tsun-Yung KUO , Charles CHEN , Chung-Chin WU , Yi-Jiun LIN , Meei-Yun LIN , Yu-Chi WU

IPC分类号： C07K14/005 , A61P31/14 , A61K39/215

摘要： The present disclosure relates to immunogenic compositions comprising a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen, and a toll-like receptor 9 (TLR9) agonist, such as an oligonucleotide comprising an unmethylated cytidine-phospho-guanosine (CpG) motif. The immunogenic compositions are suitable for stimulating an immune response against a SARS-CoV-2 in an individual in need thereof.

2.

发明申请
IMMUNOGENIC COMPOSITION AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) 有权

公开(公告)号：US20210308257A1

公开(公告)日：2021-10-07

申请号：US17351363

申请日：2021-06-18

申请人： Medigen Vaccine Biologics Corporation , Dynavax Technologies Corporation

发明人： Tsun-Yung KUO , Charles CHEN , Chung-Chin WU , Yi-Jiun LIN , Meei-Yun Lin , Yu-Chi WU , John Darren CAMPBELL , Robert S. JANSSEN , David NOVACK

IPC分类号： A61K39/215 , C07K14/165 , C07K14/245

摘要： The present invention relates to an immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), especially to an immunogenic composition having a recombinant SARS-CoV-2 S protein and adjuvant.

3.

发明公开
IMMUNOGENIC COMPOSITIONS AND METHODS FOR IMMUNIZATION AGAINST VARIANTS OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) 审中-公开

公开(公告)号：US20240197862A1

公开(公告)日：2024-06-20

申请号：US18592811

申请日：2024-03-01

申请人： Medigen Vaccine Biologics Corporation , Dynavax Technologies Corporation

发明人： Charles CHEN , Tsun-Yung Kuo , Chung-Chin Wu , Wei-Hsuan Tang , Chia-En Lien , Yi-Jiun Lin , Meei-Yun Lin

IPC分类号： A61K39/215 , A61K39/00 , A61P37/04 , C12N7/00

CPC分类号： A61K39/215 , A61P37/04 , C12N7/00 , A61K2039/54 , A61K2039/545 , A61K2039/55505 , A61K2039/55561 , C12N2770/20022 , C12N2770/20034 , C12N2770/20071

摘要： The present invention relates to immunogenic compositions and methods for immunization against variants of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), especially to an immunogenic composition having a recombinant SARS-CoV-2 S protein derived from Beta (B.1.351) variant and methods using an immunogenic composition derived from SARS-COV-2 Beta (B.1.351) variant.